Dolby Laboratories, Inc. (DLB) Profit Margins
Over the twelve months to 2026-06-30, Dolby Laboratories, Inc. (DLB) had gross margin 87.6%, operating margin 17.7%, net margin 16.7%, free cash flow margin 29.0%, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
DLBDolby Laboratories, Inc.Follow DLB — free
—
Price chart with a free account
- Market cap
- 5.9B
- P/E TTM
- 26.7
- Dividend yield
- 2.2%
- 52-week
- —
- Next earnings
- 17 Nov, in 24 days
| Line | FY2010 Sep 10 | FY2011 Sep 11 | FY2012 Sep 12 | FY2013 Sep 13 | FY2014 Sep 14 | FY2015 Sep 15 | FY2016 Sep 16 | FY2017 Sep 17 | FY2018 Sep 18 | FY2019 Sep 19 | FY2020 Sep 20 | FY2021 Sep 21 | FY2022 Sep 22 | FY2023 Sep 23 | FY2024 Sep 24 | FY2025 Sep 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 85.7% | 88.4% | 90.1% | 89.4% | 92.7% | 90.2% | 89.4% | 89.0% | 87.9% | 87.0% | 87.4% | 89.9% | 88.7% | 88.3% | 89.0% | 88.1% | 87.6% | |
| Operating margin | 46.5% | 44.7% | 38.8% | 27.0% | 28.5% | 22.0% | 22.6% | 22.9% | 17.4% | 20.7% | 18.8% | 26.9% | 16.5% | 16.6% | 20.3% | 19.6% | 17.7% | |
| Net margin | 30.7% | 32.2% | 28.3% | 20.8% | 21.5% | 18.7% | 18.1% | 19.1% | 4.0% | 20.5% | 19.9% | 24.2% | 14.7% | 15.4% | 20.6% | 18.9% | 16.7% | |
| FCF margin | 31.4% | 37.1% | 23.9% | 27.5% | 29.8% | 15.6% | 25.3% | 25.8% | 26.5% | 18.6% | 23.9% | 30.7% | 21.6% | 25.9% | 23.3% | 32.3% | 29.0% |
USD billions · SEC XBRL
Dolby Laboratories, Inc. — questions
- What is Dolby Laboratories, Inc.'s gross margin?
- 87.6% over the twelve months to 2026-06-30.
- What is Dolby Laboratories, Inc.'s operating margin?
- 17.7% over the twelve months to 2026-06-30.
- What is Dolby Laboratories, Inc.'s net profit margin?
- 16.7% over the twelve months to 2026-06-30.
Every figure on this page comes from Dolby Laboratories, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.